Eli Lilly and (NYSE:LLY) Coverage Initiated at StockNews.com
Eli Lilly and (NYSE:LLY) Coverage Initiated at StockNews.com
Equities researchers at StockNews.com began coverage on shares of Eli Lilly and (NYSE:LLY – Get Rating) in a research note issued to investors on Thursday. The brokerage set a "buy" rating on the stock.
股票研究人員在股票新聞網開始報導 禮來公司和 (紐約證券交易所:LLY — 獲得評分) 在星期四發給投資者的研究報告中。經紀公司對股票設定了「買入」評級。
A number of other analysts have also commented on LLY. JPMorgan Chase & Co. lifted their price target on Eli Lilly and from $380.00 to $400.00 in a report on Wednesday, December 14th. Societe Generale cut shares of Eli Lilly and from a "hold" rating to a "sell" rating and set a $278.00 target price on the stock. in a research note on Wednesday, February 15th. Cowen increased their target price on shares of Eli Lilly and from $390.00 to $430.00 and gave the company an "outperform" rating in a research report on Monday, December 5th. Guggenheim increased their price objective on Eli Lilly and from $399.00 to $401.00 and gave the company a "buy" rating in a report on Wednesday, December 7th. Finally, Wells Fargo & Company raised Eli Lilly and from an "equal weight" rating to an "overweight" rating and upped their price target for the company from $360.00 to $375.00 in a research report on Monday, March 13th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and twelve have assigned a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $382.05.
許多其他分析師也對 LLY 進行了評論。摩根大通公司在 12 月 14 日（星期三）的一份報告中，摩根大通公司對伊利利的價格目標從 380.00 美元提高至 400.00 美元。法興銀行下調 Eli Lilly 的股份，並從「持有」評級為「賣出」評級，並設定 278.00 美元的股票目標價格。在 2 月 15 日（星期三）的研究報告中。考文提高了對禮來公司股票的目標價格，從 390.00 美元至 430.00 美元，並在 12 月 5 日星期一的研究報告中給該公司「跑贏大市」評級。古根海姆將其對禮來公司的價格目標從 399.00 美元提高到 401.00 美元，並在 12 月 7 日星期三的一份報告中給予該公司「買入」評級。最後，富國銀行公司在 3 月 13 日星期一的研究報告中將 Eli Lilly 和從「同等權重」評級提高到「超重」評級，並將公司的價格目標從 360.00 美元提高到 375.00 美元。一位研究分析師對該股票進行了賣出評級，其中兩人發出了持有評級，而十二名則為該股分配了買入評級。根據 MarketBeat 的數據，該公司的共識評級為「中等買入」，平均目標價為 382.05 美元。
Eli Lilly and Stock Down 0.1 %
禮來禮來和股票下跌 0.1%
Shares of NYSE LLY traded down $0.35 during trading on Thursday, hitting $329.18. The stock had a trading volume of 8,679,808 shares, compared to its average volume of 3,257,667. The firm has a fifty day moving average of $335.87 and a two-hundred day moving average of $341.18. The company has a market capitalization of $312.82 billion, a PE ratio of 47.71, a PEG ratio of 1.87 and a beta of 0.36. The company has a debt-to-equity ratio of 1.37, a current ratio of 1.05 and a quick ratio of 0.80. Eli Lilly and has a 12 month low of $276.83 and a 12 month high of $384.44.
紐約證券交易所股票周四交易期間下跌 0.35 美元，觸及 329.18 美元。該股票的交易量為 8,679,808 股，而其平均交易量為 3,257,667 股。該公司有一個五十天移動平均線 335.87 美元和兩百日移動平均線 341.18 美元。該公司的市值為 3128.2 億美元，私募股權比率為 47.71，掛鉤比率為 1.87，測試版為 0.36。該公司的債務與權益比率為 1.37，流動比率為 1.05，快速比率為 0.80。禮來公司擁有 12 個月低點 276.83 美元和 12 個月高點 384.44 美元。
Eli Lilly and (NYSE:LLY – Get Rating) last released its quarterly earnings results on Thursday, February 2nd. The company reported $2.09 earnings per share for the quarter, topping the consensus estimate of $1.83 by $0.26. Eli Lilly and had a net margin of 21.88% and a return on equity of 73.61%. The business had revenue of $7.30 billion for the quarter, compared to analysts' expectations of $7.39 billion. During the same period in the previous year, the company earned $2.49 earnings per share. The firm's revenue for the quarter was down 8.7% compared to the same quarter last year. As a group, equities research analysts forecast that Eli Lilly and will post 8.48 EPS for the current fiscal year.
禮來公司和（紐約證交所代碼：LLY-獲取評級）最近一次公佈其季度盈利業績於 2 月 2 日（星期四）。該公司報告了本季度每股盈利 2.09 美元，超過了 1.83 美元的共識估計高出 0.26 美元。禮來和有 21.88％ 的淨利潤率和 73.61％ 的權益回報率。該業務本季度的營收為 730 億美元，而分析師的預期為 73.9 億美元。在上一年同期，該公司獲得了每股 2.49 美元的收益。與去年同期相比，該公司該季度的收入下降了 8.7%。作為一個集團，股票研究分析師預測，Eli Lilly 並將在本財政年度公佈 8.48 每股盈利。
Insider Buying and Selling at Eli Lilly and
在 Eli 禮來和內幕購買和出售
In other news, EVP Anne E. White sold 2,500 shares of the stock in a transaction on Friday, February 10th. The shares were sold at an average price of $342.76, for a total value of $856,900.00. Following the transaction, the executive vice president now owns 60,426 shares of the company's stock, valued at approximately $20,711,615.76. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 0.12% of the stock is currently owned by company insiders.
在其他消息中，執行副總裁安妮 ·E· 懷特於 2 月 10 日（星期五）在一次交易中出售了該股票的 2,500 股。這些股票以 342.76 美元的平均價格出售，總價值為 856,900.00 美元。交易完成後，執行副總裁現擁有該公司股票的 60,426 股股份，價值約為 20,711,615.76 美元。出售是在與證券交易委員會的法律檔案中披露的，該交易可通過以下方式獲得 這個鏈接。0.12％ 的股票目前由公司內部人士擁有。
Hedge Funds Weigh In On Eli Lilly and
對沖基金權衡禮來和
Several institutional investors have recently modified their holdings of LLY. B. Riley Wealth Advisors Inc. grew its position in Eli Lilly and by 11.5% during the fourth quarter. B. Riley Wealth Advisors Inc. now owns 39,673 shares of the company's stock valued at $14,514,000 after acquiring an additional 4,083 shares during the last quarter. Claro Advisors LLC grew its holdings in shares of Eli Lilly and by 16.9% during the 4th quarter. Claro Advisors LLC now owns 1,310 shares of the company's stock valued at $479,000 after purchasing an additional 189 shares during the last quarter. Mather Group LLC. raised its position in Eli Lilly and by 12.8% in the 4th quarter. Mather Group LLC. now owns 5,188 shares of the company's stock worth $1,898,000 after purchasing an additional 588 shares during the period. Capital Asset Advisory Services LLC lifted its stake in Eli Lilly and by 21.7% in the fourth quarter. Capital Asset Advisory Services LLC now owns 4,617 shares of the company's stock worth $1,694,000 after purchasing an additional 824 shares during the last quarter. Finally, Great Lakes Retirement Inc. purchased a new stake in Eli Lilly and during the fourth quarter valued at about $1,924,000. 82.13% of the stock is currently owned by institutional investors.
一些機構投資者最近修改了他們對 LLY 的持有量。萊利財富顧問公司在第四季度增長了在禮來利和 11.5％ 的地位。萊利財富顧問公司現在擁有該公司 39,673 股股票，價值為 14,514,000 美元，在上一季度額外收購 4,083 股後。克拉羅顧問有限責任公司增長了伊利禮來公司的股份，並通過 16.9% 在第四季度.卡拉羅顧問有限責任公司現在擁有 1,310 股價值 479,000 美元的公司股票後，在上一季度額外購買 189 股。馬瑟集團有限責任公司. 在第四季度提高了其在伊利利和 12.8% 的地位.在期內，馬瑟集團有限公司在期內額外購買 588 股股份後，擁有該公司股份的 5,188 股股份，價值 1,898,000 港元。資本資產諮詢服務有限責任公司在第四季度取消了 Eli Lilly 的股份和 21.7％ 的股份。資本資產諮詢服務有限責任公司現在擁有該公司股票的 4,617 股價值 1,694,000 美元，在上個季度額外購買 824 股後。最後，大湖區退休公司購買了 Eli Lilly 的新股份，在第四季度，價值約為 1,924,000 美元。82.13％ 的股票目前由機構投資者擁有。
Eli Lilly and Company Profile
禮來及公司簡介
(Get Rating)
(取得評分)
Eli Lilly & Co engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.
禮來公司從事發現，開發，製造和銷售醫藥產品。該公司的產品包括糖尿病，腫瘤學，免疫學，神經科學以及其他產品和療法。該公司由 Eli 禮來於 1876 年 5 月成立，總部位於印第安納波利斯。
Read More
閱讀更多
- Get a free copy of the StockNews.com research report on Eli Lilly and (LLY)
- MarketBeat Week in Review – 3/13 – 3/17
- This Small Tech With Big Growth Prospects Is Nearing A Buy Point
- Don't Chase FedEx Higher, Wait For The Pullback
- 3 Stocks For A Defensive Tech Portfolio
- Milk the Dividends on These 3 Cash Cows
- 獲取有關伊利禮來和（LLY）的研究報告的免費副本
- 市場節拍週的回顧 — 3 月 13 日 — 3/17
- 這種具有巨大增長前景的小技術正接近買點
- 不要追逐聯邦快遞更高，等待回調
- 3 個防禦性技術投資組合的股票
- 牛奶這些 3 現金奶牛的股息
Receive News & Ratings for Eli Lilly and Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eli Lilly and and related companies with MarketBeat.com's FREE daily email newsletter.
接收 Eli 禮來和每日的新聞和評分 -在下面輸入您的電子郵件地址，以通過 MarketBeat.com 的免費每日電子郵件通訊接收 Eli Lilly 和相關公司的最新新聞和分析師評級的簡要每日摘要。
譯文內容由第三人軟體翻譯。